Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
18,515
archived clinical trials in
Lymphoma

PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Colorado Blood Cancer Institute
mi
from
Denver, CO
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Colorado Blood Cancer Institute
mi
from
Denver, CO
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Lynn Cancer Institute
mi
from
Boca Raton, FL
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Lynn Cancer Institute
mi
from
Boca Raton, FL
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Bond Clinic
mi
from
Winter Haven, FL
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Bond Clinic
mi
from
Winter Haven, FL
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Augusta University
mi
from
Augusta, GA
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Rush University Medical Center
mi
from
Chicago, IL
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Horizon Oncology Research, Inc.
mi
from
Lafayette, IN
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Horizon Oncology Research, Inc.
mi
from
Lafayette, IN
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
UHC Oncology
mi
from
Lafayette, LA
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
UHC Oncology
mi
from
Lafayette, LA
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Western Maryland Health System, Inc.
mi
from
Cumberland, MD
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Western Maryland Health System, Inc.
mi
from
Cumberland, MD
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Mercy Health Saint Mary's
mi
from
Grand Rapids, MI
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Mercy Health Saint Mary's
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
St. John Hospital and Medical Center
mi
from
Grosse pointe Woods, MI
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
St. John Hospital and Medical Center
mi
from
Grosse pointe Woods, MI
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Michigan State University
mi
from
Lansing, MI
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Michigan State University
mi
from
Lansing, MI
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Duke University
mi
from
Durham, NC
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Bon Secours Saint Francis Cancer Center
mi
from
Greenville, SC
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Bon Secours Saint Francis Cancer Center
mi
from
Greenville, SC
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Avera Research Institute
mi
from
Sioux Falls, SD
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Avera Research Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Baylor Research Institute
mi
from
Dallas, TX
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Baylor Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
M.D. Anderson Cancer Center
mi
from
Houston, TX
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Tyler Hematology Oncology PA
mi
from
Tyler, TX
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Tyler Hematology Oncology PA
mi
from
Tyler, TX
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Peninsula Cancer Institute
mi
from
Newport News, VA
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Peninsula Cancer Institute
mi
from
Newport News, VA
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Medical Oncology Associates PS
mi
from
Spokane, WA
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Medical Oncology Associates PS
mi
from
Spokane, WA
Click here to add this to my saved trials
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated:  7/11/2016
Fundacion de Investigacion
mi
from
San Juan,
PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)
A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Status: Enrolling
Updated: 7/11/2016
Fundacion de Investigacion
mi
from
San Juan,
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Southern California Permanente Medical Group
mi
from
Downey, CA
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Southern California Permanente Medical Group
mi
from
Downey, CA
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
University of California Davis Cancer Center
mi
from
Sacramento, CA
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Connecticut Children's Medical Center
mi
from
Hartford, CT
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Florida Hospital
mi
from
Orlando, FL
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Nemours Children's Clinic - Pensacola
mi
from
Pensacola, FL
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Nemours Children's Clinic - Pensacola
mi
from
Pensacola, FL
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
University of Chicago
mi
from
Chicago, IL
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Saint Jude Midwest Affiliate
mi
from
Peoria, IL
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Saint Jude Midwest Affiliate
mi
from
Peoria, IL
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Kosair Children's Hospital
mi
from
Louisville, KY
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Kosair Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Winthrop University Hospital
mi
from
Mineola, NY
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
New York Medical College
mi
from
Valhalla, NY
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Lehigh Valley Hospital - Muhlenberg
mi
from
Bethlehem, PA
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Lehigh Valley Hospital - Muhlenberg
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Geisinger Medical Center
mi
from
Danville, PA
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Rhode Island Hospital
mi
from
Providence, RI
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
East Tennessee Children's Hospital
mi
from
Knoxville, TN
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
East Tennessee Children's Hospital
mi
from
Knoxville, TN
Click here to add this to my saved trials
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated:  7/12/2016
Dell Children's Medical Center of Central Texas
mi
from
Austin, TX
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children With Newly Diagnosed High Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 7/12/2016
Dell Children's Medical Center of Central Texas
mi
from
Austin, TX
Click here to add this to my saved trials